Last reviewed · How we verify

perioperative treatment

Centre Francois Baclesse · Phase 2 active Small molecule

perioperative treatment is a Small molecule drug developed by Centre Francois Baclesse. It is currently in Phase 2 development.

At a glance

Generic nameperioperative treatment
SponsorCentre Francois Baclesse
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about perioperative treatment

What is perioperative treatment?

perioperative treatment is a Small molecule drug developed by Centre Francois Baclesse.

Who makes perioperative treatment?

perioperative treatment is developed by Centre Francois Baclesse (see full Centre Francois Baclesse pipeline at /company/centre-francois-baclesse).

What development phase is perioperative treatment in?

perioperative treatment is in Phase 2.

Related